Stock listing
A2N9D9 Stock Price, News, Filings & Events — Moderna, Inc.
Selected listing: A2N9D9 · LSX · EUR · DE
This page tracks Moderna, Inc.'s A2N9D9:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2N9D9:LSX. A2N9D9:LSX is the stock-level entry point for investors researching Moderna, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A2N9D9:LSX
- Asset type
- Stock
- Market cap
- $55.09B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- LSX
- Currency
- EUR
Moderna, Inc. A2N9D9:LSX stock context
This page tracks Moderna, Inc.'s A2N9D9:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2N9D9:LSX. A2N9D9:LSX is the stock-level entry point for investors researching Moderna, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Moderna, Inc.
Moderna Announces Pricing of Upsized $2.6 Billion Offering of Convertible Senior Notes
August 28, 2026
Moderna Receives U.S. FDA Approval for Updated 2026-2027 COVID-19 Vaccines
August 27, 2026
Moderna Announces Proposed Private Placement of $2.0 Billion of Convertible Senior Notes
August 27, 2026
Moderna Receives U.S. FDA Approval for Influenza Vaccine mFLUSIVA
August 5, 2026
Moderna Announces Initiation of Phase 1 Clinical Trial of mRNA-1469, Moderna's Investigational Vaccine Against Bundibugyo Ebolavirus
August 4, 2026
Moderna, Inc. earnings calls
Moderna, Inc. (MRNA) Q2 2026 Earnings Call
July 31, 2026 · Replay with transcript and chapters
Moderna, Inc. (MRNA) Q1 2026 Earnings Call
May 1, 2026 · Replay with transcript and chapters
Moderna, Inc. (MRNA) Q4 2025 Earnings Call
February 13, 2026 · Replay with transcript and chapters
Moderna, Inc. (MRNA) Q3 2025 Earnings Call
November 6, 2025 · Replay with transcript and chapters
Moderna, Inc. (MRNA) Q2 2025 Earnings Call
August 1, 2025 · Replay with transcript and chapters
Moderna, Inc. (MRNA) Q1 2025 Earnings Call
May 1, 2025 · Replay with transcript and chapters
Research Moderna, Inc.
Moderna, Inc. investor report
Review AI stock analysis and investor report context for A2N9D9:LSX.
Moderna, Inc. company profile
View the public company page for Moderna, Inc. on 6ix.
Moderna, Inc. news
Read company news and market updates connected to Moderna, Inc..
Moderna, Inc. investor events
Find investor webinars, events, and replay context for Moderna, Inc..
Alternate listings
MRNA:NASDAQ
US · USD
Alternate listing for Moderna, Inc.; the primary context on this page is A2N9D9:LSX.
0QF:GETTEX
DE · EUR
Alternate listing for Moderna, Inc.; the primary context on this page is A2N9D9:LSX.
1MRNA:MIL
IT · EUR
Alternate listing for Moderna, Inc.; the primary context on this page is A2N9D9:LSX.
0QF:XETR
DE · EUR
Alternate listing for Moderna, Inc.; the primary context on this page is A2N9D9:LSX.
0QF:TRADEGATE
DE · EUR
Alternate listing for Moderna, Inc.; the primary context on this page is A2N9D9:LSX.
MRNA:BCBA
AR · ARS
Alternate listing for Moderna, Inc.; the primary context on this page is A2N9D9:LSX.
MRNA:BMV
MX · MXN
Alternate listing for Moderna, Inc.; the primary context on this page is A2N9D9:LSX.
M1RN34:BMFBOVESPA
BR · BRL
Alternate listing for Moderna, Inc.; the primary context on this page is A2N9D9:LSX.
MRNA:BOATS
US · USD
Alternate listing for Moderna, Inc.; the primary context on this page is A2N9D9:LSX.
4MRNA:EUROTLX
IT · EUR
Alternate listing for Moderna, Inc.; the primary context on this page is A2N9D9:LSX.
A2N9D9:LS
DE · EUR
Alternate listing for Moderna, Inc.; the primary context on this page is A2N9D9:LSX.
0A45:LSIN
GB · USD
Alternate listing for Moderna, Inc.; the primary context on this page is A2N9D9:LSX.